Insilico Medicine Hong Kong Limited
Clinical trials sponsored by Insilico Medicine Hong Kong Limited, explained in plain language.
-
New pill aims to slow lung scarring in IPF patients
Disease control Recruiting nowThis study tests an oral drug called INS018_055 in 40 adults with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and breathing problems. The main goal is to check the drug's safety over 12 weeks. Researchers will also measure how the drug moves through t…
Phase: PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated May 02, 2026 00:29 UTC
-
New pill could tame gut inflammation in colitis patients
Disease control Recruiting nowThis study tests a new drug called ISM5411 in 80 adults with active ulcerative colitis, a condition causing inflammation in the colon. Participants will receive either the drug or a placebo to see if it is safe and helps control symptoms. The goal is to manage the disease, not cu…
Phase: PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated May 02, 2026 00:28 UTC